Tim Girton
About Tim Girton
Tim Girton is the Vice President of Research and Development for Interventional Cardiology at Boston Scientific, with a background in chemical and biomedical engineering.
Current Role at Boston Scientific
Tim Girton has held the position of Vice President, Research and Development, Interventional Cardiology at Boston Scientific since 2013. Based in Maple Grove, MN, he has focused on advancing the company's R&D efforts in the interventional cardiology sector. His role includes developing innovative solutions to address clinical issues in cardiology and leading a team committed to advancing the field through research and development.
Previous Roles at Boston Scientific
Before his current role, Tim Girton served as the Director of R&D at Boston Scientific from 2008 to 2013. In this position, he contributed to the company's research and development initiatives over a span of five years. Prior to that, he worked in various capacities including Chief Engineer, Manager, and Engineer from 1998 to 2008, accumulating a decade of experience in engineering and managerial roles within the company.
Educational Background
Tim Girton earned his Doctor of Philosophy (Ph.D.) in Chemical Engineering and Vascular Tissue Engineering from the University of Minnesota-Twin Cities, where he studied from 1993 to 1998. He also holds a Bachelor's degree in Bioengineering and Biomedical Engineering from the University of Pennsylvania, completing his studies there from 1989 to 1993.
Strategic Contributions
In his role as Vice President of R&D at Boston Scientific, Tim Girton has been instrumental in developing strategies that balance risk and revenue. His efforts are focused on driving growth in the interventional cardiology business. He emphasizes the importance of fostering the next generation of R&D leaders within the organization, ensuring the continued advancement and innovation in cardiology research and solutions.
Leadership in Research and Development
Tim Girton leads an R&D organization dedicated to solving clinical issues in cardiology through innovative solutions. His leadership is characterized by a commitment to advancing the field of interventional cardiology, guiding a team of researchers and developers in pursuing cutting-edge technological and clinical advancements.